ESOPJun 26, 2026, 04:16 PM
Crescent Biopharma Grants 65,100 Stock Options to New Employees
AI Summary
Crescent Biopharma, Inc. announced that its independent Compensation Committee approved the grant of options to purchase an aggregate of 65,100 ordinary shares to three non-executive employees. These equity inducement awards were made under the Company's 2025 Employment Inducement Incentive Award Plan, with an exercise price of $16.99 per share. The options, which have a 10-year term, will vest over four years, subject to continuous employment.
Key Highlights
- Crescent Biopharma granted options for 65,100 ordinary shares.
- Awards were given to three non-executive employees as inducement awards.
- Options were granted under the 2025 Employment Inducement Incentive Award Plan.
- Exercise price is $16.99, based on June 25, 2026 closing price.
- Options have a 10-year term and vest over four years (1/4th after 1st year, then monthly).
Price Impact
More from CBIO